2021
DOI: 10.1016/j.xhgg.2021.100033
|View full text |Cite
|
Sign up to set email alerts
|

PTPN4 germline variants result in aberrant neurodevelopment and growth

Abstract: Summary Protein-tyrosine phosphatases (PTPs) are pleomorphic regulators of eukaryotic cellular responses to extracellular signals that function by modulating the phosphotyrosine of specific proteins. A handful of PTPs have been implicated in germline and somatic human disease. Using exome sequencing, we identified missense and truncating variants in PTPN4 in six unrelated individuals with varying degrees of intellectual disability or developmental delay. The variants occurred … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
5
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(6 citation statements)
references
References 65 publications
(76 reference statements)
1
5
0
Order By: Relevance
“…HOPE analyses indeed position the L72S structural change quite close to the shallow binding cleft located between the FERM subdomains ( Figure 2 ). Recently six additional mutations in PTPN4 were implicated to cause (neuro) developmental disorders ( Chmielewska et al, 2021 ); five are documented in dbSNP (rs1677776998; rs1678083679; rs1678390512; rs1679218434; rs1259252500) and one (c.2171T>C p.I724T) is not, but all are predicted to disrupt PTP-MEG1 function ( Chmielewska et al, 2021 ). Also in the ClinVar database PTPN4 SNPs rs1679434397 (c.2491C>A, p.L831I) and, once more, rs1679218434 (c.1738G>T, p.D580Y) have been connected to intellectual disability and autism spectrum disorder (ASD), but functional evidence is currently lacking.…”
Section: Documented Genetic Variabilitymentioning
confidence: 99%
“…HOPE analyses indeed position the L72S structural change quite close to the shallow binding cleft located between the FERM subdomains ( Figure 2 ). Recently six additional mutations in PTPN4 were implicated to cause (neuro) developmental disorders ( Chmielewska et al, 2021 ); five are documented in dbSNP (rs1677776998; rs1678083679; rs1678390512; rs1679218434; rs1259252500) and one (c.2171T>C p.I724T) is not, but all are predicted to disrupt PTP-MEG1 function ( Chmielewska et al, 2021 ). Also in the ClinVar database PTPN4 SNPs rs1679434397 (c.2491C>A, p.L831I) and, once more, rs1679218434 (c.1738G>T, p.D580Y) have been connected to intellectual disability and autism spectrum disorder (ASD), but functional evidence is currently lacking.…”
Section: Documented Genetic Variabilitymentioning
confidence: 99%
“…In the brain, PTPMEG/PTPN4 is not only mainly expressed in cerebellum and thalamus, but also in the cortex and hippocampus, distributing in neurons within the cytoplasm, axons, dendrites, dendritic spines and PSD [41,47 ▪▪ ,48]. PTPMEG/PTPN4 has been involved in neurodevelopmental disorders [47 ▪▪ ,48,49] and glutamatergic synaptic transmission and plasticity [27 ▪▪ ,41,50].…”
Section: Ptpmeg/ptpn4 As a Ubiquitination Substrate Downstream Neuron...mentioning
confidence: 99%
“…PTPMEG/PTPN4 is a large protein of 926 amino acids containing an N-terminal FERM (Band 4.1, Ezrin, Radixin and Moesin) domain that mediates interactions with the plasma membrane, a PDZ (PSD-95/Dlg/ZO-1) domain that interacts with PDZ-ligand domains present in certain glutamatergic receptors and a C-terminal catalytic tyrosine phosphatase domain [40–46]. In the brain, PTPMEG/PTPN4 is not only mainly expressed in cerebellum and thalamus, but also in the cortex and hippocampus, distributing in neurons within the cytoplasm, axons, dendrites, dendritic spines and PSD [41,47 ▪▪ ,48]. PTPMEG/PTPN4 has been involved in neurodevelopmental disorders [47 ▪▪ ,48,49] and glutamatergic synaptic transmission and plasticity [27 ▪▪ ,41,50].…”
Section: Ptpmeg/ptpn4 As a Ubiquitination Substrate Downstream Neuron...mentioning
confidence: 99%
See 2 more Smart Citations